WHO recommends highly successful COVID-19 therapy and calls for wide geographical distribution and transparency from originator - World Health Organization


4/21/2022 12:00:00 AM3 yearsago
by World Health Organization: WHO

<p>Today, WHO made a strong recommendation for nirmatrelvir and ritonavir, sold under the name Paxlovid, for mild and moderate COVID-19 patients at highest risk of hospital admission, calling it the best therapeutic choice for high-risk patients to date. Howe…

Today, WHO made a strong recommendation for nirmatrelvir and ritonavir, sold under the name Paxlovid, for mild and moderate COVID-19 patients at highest risk of hospital admission, calling it the bes… [+3643 chars]

full article...